ALLR - What's Going On With Allarity Therapeutics Stock? | Benzinga
Allarity Therapeutics Inc (NASDAQ: ALLR) shares are trading higher Thursday. The company published clinical data in a peer-reviewed journal late Wednesday.
What Happened: Allarity published a clinical validation of a novel drug-specific DRP-companion diagnostic (CDx) for dovitinib in PLOS ONE Wednesday around market close. The data highlighted a subgroup of advanced renal cell carcinoma (RCC) patients that have improved clinical ...